Share This:

Abstract for TR-249 - Amosite Asbestos (CASRN 12172-73-5)


Lifetime Carcinogenesis Studies of Amosite Asbestos (CAS No. 12172-73-5) in Syrian Golden Hamsters (Feed Studies)

Link to the full study report in PDF. If you have difficulty accessing the document, please send email to the NTP Webmaster [ Send Email ] and identify documents/pages for which access is required.

Structural Formula: (FeC2+Mg)6· Si8O22(OH)2

Carcinogenesis studies of amosite asbestos were conducted by administering diets containing 1% of the asbestos in pellets from the conception of the mothers through the lifetime of male and female Syrian golden hamsters. Control groups consisted of 127 male and 126 female hamsters and the amosite asbestos groups consisted of 252 male and 254 female hamsters.

No adverse effect on body weight gain or survival was observed from treatment with amosite asbestos. Neither of the amosite asbestos groups showed increased neoplasia in any organ or tissue compared to the control groups.

Under the conditions of these studies, the ingestion of amosite asbestos at a level of 1% in the diet for their lifetime was not toxic and did not cause a carcinogenic response in male and female Syrian golden hamsters.



Levels of Evidence of Carcinogenicity:
Sex Species Results
Male Hamsters: Negative
Female Hamsters: Negative

Note: Amosite Asbestos was subsequently tested in F344 rats administered in feed (See TR-279, reported 1990).

Report Date: November 1983

Target Organs & Incidences from 2-year Studies

Return to Long Term Abstracts